Free fatty acids and pathogenesis of type 2 diabetes mellitus

Trends in Endocrinology and Metabolism

Volumn 11, Issue 9, 2000, Pages 351-356

  Bergman, Richard N ^a   Ader, Marilyn ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUCOSE; INSULIN;

ENERGY BALANCE; FATTY ACID BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LIVER METABOLISM; MUSCLE BLOOD FLOW; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMAL; DIABETES MELLITUS, NON-INSULIN-DEPENDENT; FATTY ACIDS, NONESTERIFIED; HUMAN; INSULIN; INSULIN RESISTANCE; LIVER; OBESITY IN DIABETES; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0033779714     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(00)00323-4     Document Type: Review

References (54)

1. β-Cells in type II diabetes mellitus (Banting Lecture)
2. Toward physiological understanding of glucose tolerance: Minimal-model approach (Lilly Lecture)
3. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance
4. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus: Prospective studies of Pima Indians
5. Pathogenic factors responsible for glucose intolerance in patients with NIDDM
6. Different aetiologies of type 2 (non-insulin-dependent) diabetes mellitus in obese and non-obese subjects
7. The role of non-esterified fatty acids in the deterioration of glucose tolerance in Caucasian subjects: Results of the Paris Prospective Study
8. A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM
9. Twenty-four-hour insulin secretion rates, circulating concentrations of fuel substrates and gut incretin hormones in healthy offspring of Type II (non-insulin-dependent) diabetic parents: Evidence of several aberrations
10. Hemodynamic actions of insulin
11. Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation
12. Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production
13. New concepts in extracellular signaling for insulin action: The single gateway hypothesis
14. Insulin resistance in dogs with transendothelial transport defect
15. Glucose fatty acid interactions and the regulation of glucose disposal
16. Insulin resistance, lipid and fatty acid concentrations in 867 healthy Europeans
17. Fatty acids and insulin resistance
18. Mechanism of free fatty acid-induced insulin resistance in humans
19. Perturbation of fuel homeostasis caused by overexpression of the glucose-6-phosphatase catalytic subunit in liver of normal rats
20. Measurement of intracellular triglyceride stores by H spectroscopy: Validation in vivo
21. 1H NMR spectroscopy study
22. Relation of triglyceride stores in skeletal muscle cells to central obesity and insulin sensitivity in Europeans and South Asian men
23. 13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic patients
24. Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes
25. Are the β-cell signaling molecules malonyl-coA and cytosolic long-chain acyl-coA implicated in multiple tissue defects of obesity and NIDDM?
26. Reversibility of insulin resistance in obese diabetic patients: Role of plasma lipids
27. Essentiality of circulating fatty acids for glucose-stimulated insulin secretion in the fasted rat
28. Acute lowering of plasma fatty acids lowers basal insulin secretion in diabetic and nondiabetic subjects
29. Effects of fatty acids and ketone bodies on basal insulin secretion in type 2 diabetes
30. A 48-hour lipid infusion in the rat time-dependently inhibits glucose-induced insulin secretion and B-cell oxidation through a process likely coupled to fatty acid oxidation
31. Prolonged elevation of plasma free fatty acids desensitizes the insulin secretory response to glucose in vivo in rats
32. Effects of a 48 hour fat infusion on insulin secretion and glucose utilization
33. Regulation of fatty acid homeostasis in cells: Novel role of leptin
34. OB-Rb gene transfer to leptin-resistant islets reverses diabetogenic phenotype
35. Fatty acid-induced β cell apoptosis: A link between obesity and diabetes
36. Direct anti-diabetic effect of leptin through triglyceride depletion of tissues
37. Role of nitric oxide in obesity-induced beta cell disease
38. Congenital leptin deficiency is associated with severe early-onset obesity in humans
39. Failure to adequately adapt to reduced insulin sensitivity with increased insulin secretion in women with impaired glucose tolerance
40. Reduced β-cell function contributes to impaired glucose tolerance in dogs made obese by high-fat feeding
41. The longitudinal compensation for fat induced insulin resistance includes reduced insulin clearance and enhanced B-cell response
42. Non-esterified fatty acids and the liver: Why is insulin secreted into the portal vein?
43. Relationship of body fat topography to insulin sensitivity and metabolic profiles in premenopausal women
44. Control of hepatic glucose production by omental lipolysis
45. Rapid oscillations in omental lipolysis are independent of changing insulin levels in vivo
46. Control of gluconeogenesis in liver: IV. Differential effects of fatty acids and glucagon on ketogenesis and gluconeogenesis in the perfused rat liver
47. Causal linkage between insulin regulation of lipolysis and liver glucose output
48. Central role of the adipocyte in insulin resistance
49. No reduction in total hepatic glucose output by inhibition of gluconeogenesis with ethanol in NIDDM patients
50. Evidence for dual control mechanism regulating hepatic glucose output in nondiabetic men
51. Induction of hepatic glucose-6-phosphatase gene expression by lipid infusion
52. Alterations of carbohydrate and lipid intermediary metabolism during inhibition of glucose-6-phosphatase in rats
53. Visceral fat and insulin resistance - Causative or correlative?
54. Metabolic implications of body fat distribution